Lupin Pharmaceuticals Inc. recalls Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202
Recalled December 28, 2022 · FDA recall D-0089-2023 · Lupin Pharmaceuticals
Hazard
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit. · FDA Class II
Units
23,736
Sold at
Product was distributed by major distribution chains nationwide.
Description
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Product
Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →